Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen

Show other versions (1)

Bibliographic Details
Main Authors:	Léna Angelo, Andrew Vaillant, Matthieu Blanchet, Patrick Labonté
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619774/?tool=EBI

Similar Items

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.
by: Léna Angelo, et al.
Published: (2023-01-01)

2139
by: Nilay Shah, et al.
Published: (2017-09-01)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
by: Michel Bazinet, et al.
Published: (2021-02-01)

CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections
by: Ulyana I. Bartosh, et al.
Published: (2023-12-01)

Hepatitis B virus and site-specific nucleases: effects of genetic modifications in CRISPR/Cas9 on antiviral activity
by: A. P. Kostyusheva, et al.
Published: (2019-07-01)

Targeting Hepatitis B Virus With CRISPR/Cas9
by: Christoph Seeger, et al.
Published: (2014-01-01)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
by: Choongho Lee
Published: (2019-04-01)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
by: Jiangtao Ren, et al.
Published: (2017-04-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
by: Bo Cai, et al.
Published: (2023-05-01)

The Impact of CRISPR-Cas System on Antiviral Therapy
by: Hadi Bayat, et al.
Published: (2018-11-01)

The Application of CRISPR/Cas Systems for Antiviral Therapy
by: Helen J. E. Baddeley, et al.
Published: (2021-10-01)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
by: Gilles Darcis, et al.
Published: (2019-03-01)

Evolution of giant pandoravirus revealed by CRISPR/Cas9
by: Hugo Bisio, et al.
Published: (2023-01-01)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
by: Shuliang Chen, et al.
Published: (2018-01-01)

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
by: Faseeha Noordeen, et al.
Published: (2015-01-01)

In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
by: Rebeca Martinez-Turrillas, et al.
Published: (2022-06-01)

The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
by: Wei Lv MSc, et al.
Published: (2021-09-01)

Crispr/Cas9 Mediated Inactivation of Argonaute 2 Reveals its Differential Involvement in Antiviral Responses
by: Márta Ludman, et al.
Published: (2017-04-01)

Development and Applications of CRISPR-Cas9 for Genome Engineering
by: Hsu, Patrick, et al.
Published: (2017)

CRISPR/Cas9 in Gastrointestinal Malignancies
by: André Jefremow, et al.
Published: (2021-11-01)

Genome engineering using the CRISPR-Cas9 system
by: Ran, F. Ann, et al.
Published: (2016)

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
by: Shlomai, Amir, et al.
Published: (2017)

Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication
by: Koollawat Chupradit, et al.
Published: (2022-11-01)

CRISPR/CAS9 SYSTEM : APPLICATIONS AND TECHNOLOGY /
by: Bertelsen, Alfred A., editor
Published: (2019)

CRISPR/Cas9 as a Mutagenic Factor
by: Andrey R. Shumega, et al.
Published: (2024-01-01)

CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01)

Multidimensional chemical control of CRISPR–Cas9
by: Maji, Basudeb, et al.
Published: (2017)

Target specificity of the CRISPR-Cas9 system
by: Wu, Xuebing, et al.
Published: (2015)

CRISPR/Cas9 Technology and Applications in Plants
by: Emine Açar, et al.
Published: (2021-01-01)

Application of CRISPR/Cas9 technology in forages
by: Qinyan Bao, et al.
Published: (2022-12-01)

CRISPR/Cas9 therapeutics: progress and prospects
by: Tianxiang Li, et al.
Published: (2023-01-01)

Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017-05-01)

CRISPR/Cas9 Technology in Translational Biomedicine
by: Elena I. Leonova, et al.
Published: (2020-04-01)

Reshuffling yeast chromosomes with CRISPR/Cas9.
by: Aubin Fleiss, et al.
Published: (2019-08-01)

CRISPR/Cas9 or prime editing? – It depends on…
by: Schenke Dirk
Published: (2020-12-01)

CRISPR/Cas9 genome editing system
by: Dhananjaya Saranath, et al.
Published: (2017-01-01)

Application of CRISPR/Cas9 in Alzheimer’s Disease
by: Likui Lu, et al.
Published: (2021-12-01)

CRISPR/Cas9 Editing of the Polyomavirus Tumor Antigens Inhibits Merkel Cell Carcinoma Growth In Vitro
by: Arturo Temblador, et al.
Published: (2019-08-01)

α-Gal antigen-deficient rabbits with GGTA1 gene disruption via CRISPR/Cas9
by: Lina Wei, et al.
Published: (2022-07-01)

Construction of Baculovirus-Inducible CRISPR/Cas9 Antiviral System Targeting BmNPV in <i>Bombyx mori</i>
by: Yujia Liu, et al.
Published: (2021-12-01)